Literature DB >> 15592901

Oesophageal manometry in early and definite systemic sclerosis.

Paolo Airò1, Domenico Della Casa, Elisabetta Danieli, Guido Missale, Roberto Cattaneo, Renzo Cestari.   

Abstract

The objective of this study was to evaluate the oesophageal dysfunction in patients with "early" systemic sclerosis (SSc), as defined by LeRoy and Medsger, to compare it with that of patients with definite SSc, and to correlate it with other features of the disease. Oesophageal manometry results were retrospectively evaluated in 181 patients classified by the 2001 LeRoy and Medsger criteria and the 1980 American College of Rheumatology (ACR) criteria: group 1: limited SSc: Raynaud's phenomenon plus specific nailfold capillaroscopy abnormalities and/or autoantibodies; group 2: limited cutaneous SSc not satisfying the ACR criteria (lcSSc ACR-); group 3: lcSSc ACR+; group 4: diffuse cutaneous SSc. Peristaltic abnormalities in the oesophageal body were present in 73 of 125 patients with SSc ACR+ (groups 3 and 4) compared with 13 of 56 with SSc ACR- (groups 1 and 2) (p < 0.0001). They were more severe in patients with more advanced disease (1 vs 2; 1 vs 3; 1 vs 4; 2 vs 4; p < 0.05) and in patients anti-Scl-70+ than in patients anticentromere positive (p = 0.02). Abnormalities of the lower oesophageal sphincter (LES) were present in 35 of 125 patients with SSc ACR+ and 11 of 56 with SSc ACR- (not statistically different). They were correlated with forced vital capacity (FVC) (LES pressure: p = 0.0005; LES length: p = 0.0004). Abnormalities of the oesophageal body and of the LES were found in 21 and 16% of 46 patients without oesophageal symptoms. Oesophageal manometry can detect abnormalities in a sizeable proportion of patients with "early SSc" not fulfilling the ACR criteria, including asymptomatic patients. The correlation between LES abnormalities and FVC suggests a possible causal relationship between these disease manifestations.

Entities:  

Mesh:

Year:  2004        PMID: 15592901     DOI: 10.1007/s10067-004-1049-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  39 in total

Review 1.  When is scleroderma really scleroderma?

Authors:  F M Wigley
Journal:  J Rheumatol       Date:  2001-07       Impact factor: 4.666

Review 2.  American Gastroenterological Association technical review on the clinical use of esophageal manometry.

Authors:  P J Kahrilas; R E Clouse; W J Hogan
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

3.  Identification of antibodies to acidic antigens by counterimmunoelectrophoresis.

Authors:  R M Bernstein; C C Bunn; G R Hughes
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

4.  Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma.

Authors:  L S Lonzetti; F Joyal; J P Raynauld; A Roussin; J R Goulet; E Rich; D Choquette; Y Raymond; J L Senécal
Journal:  Arthritis Rheum       Date:  2001-03

5.  Esophageal involvement and pulmonary manifestations in systemic sclerosis.

Authors:  I Marie; S Dominique; H Levesque; P Ducrotté; P Denis; M F Hellot; H Courtois
Journal:  Arthritis Rheum       Date:  2001-08

6.  Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting.

Authors:  C G Kallenberg; A A Wouda; M H Hoet; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

7.  Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. A prospective study.

Authors:  E S Weiner; S Hildebrandt; J L Senécal; L Daniels; S Noell; F Joyal; A Roussin; W Earnshaw; N F Rothfield
Journal:  Arthritis Rheum       Date:  1991-01

Review 8.  Gastrointestinal motility disorders in scleroderma.

Authors:  R W Sjogren
Journal:  Arthritis Rheum       Date:  1994-09

Review 9.  Systemic scleroderma. Clinical and pathophysiologic aspects.

Authors:  T Krieg; M Meurer
Journal:  J Am Acad Dermatol       Date:  1988-03       Impact factor: 11.527

10.  Esophageal motility disorders in the rheumatic diseases: a review of 150 patients.

Authors:  G Lapadula; P Muolo; F Semeraro; M Covelli; D Brindicci; G Cuccorese; A Francavilla; V Pipitone
Journal:  Clin Exp Rheumatol       Date:  1994 Sep-Oct       Impact factor: 4.473

View more
  9 in total

1.  Autoantibody profile in systemic sclerosis as a marker for esophageal and other organ involvement in Turkish populations.

Authors:  Nurten Savas; Ulku Dagli; Esin Ertugrul; Sedef Kuran; Burhan Sahin
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

Review 2.  The role of high-resolution manometry in the assessment of upper gastrointestinal involvement in systemic sclerosis: a systematic review.

Authors:  Wouter Schutyser; Ludovic Cruyt; Jean-Baptiste Vulsteke; Jan L Lenaerts; Ellen De Langhe
Journal:  Clin Rheumatol       Date:  2019-11-11       Impact factor: 2.980

3.  The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters.

Authors:  J N Kimmel; D A Carlson; M Hinchcliff; M A Carns; K A Aren; J Lee; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2016-02-27       Impact factor: 3.598

4.  Esophageal high-resolution impedance manometry alterations in asymptomatic patients with systemic sclerosis: prevalence, associations with disease features, and prognostic value.

Authors:  Serena Vettori; Salvatore Tolone; Domenico Capocotta; Rossella Chieffo; Veronica Giacco; Gabriele Valentini; Ludovico Docimo
Journal:  Clin Rheumatol       Date:  2018-02-13       Impact factor: 2.980

Review 5.  A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic Sclerosis.

Authors:  Maria-Grazia Lazzaroni; Silvia Piantoni; Fabrizio Angeli; Stefania Bertocchi; Franco Franceschini; Paolo Airò
Journal:  Clin Rev Allergy Immunol       Date:  2022-03-07       Impact factor: 10.817

6.  Gastroesophageal reflux disease and connective tissue disorders: pathophysiology and implications for treatment.

Authors:  Marco G Patti; Warren J Gasper; Piero M Fisichella; Ian Nipomnick; Francesco Palazzo
Journal:  J Gastrointest Surg       Date:  2008-09-03       Impact factor: 3.452

7.  Loss of Peristaltic Reserve, Determined by Multiple Rapid Swallows, Is the Most Frequent Esophageal Motility Abnormality in Patients With Systemic Sclerosis.

Authors:  Dustin A Carlson; Michael D Crowell; Jessica N Kimmel; Amit Patel; C Prakash Gyawali; Monique Hinchcliff; W Leroy Griffing; John E Pandolfino; Marcelo F Vela
Journal:  Clin Gastroenterol Hepatol       Date:  2016-04-05       Impact factor: 11.382

Review 8.  Gastrointestinal manifestations of systemic sclerosis.

Authors:  Robyn Domsic; Kenneth Fasanella; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

9.  Esophageal involvement in scleroderma: clinical, endoscopic, and manometric features.

Authors:  M Lahcene; N Oumnia; N Matougui; M Boudjella; A Tebaibia; B Touchene
Journal:  ISRN Rheumatol       Date:  2011-10-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.